Alpha Teknova Inc
NASDAQ:TKNO
Alpha Teknova Inc
Other
Alpha Teknova Inc
Other Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Alpha Teknova Inc
NASDAQ:TKNO
|
Other
-$1.2m
|
CAGR 3-Years
-56%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other
$90m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
4%
|
|
|
Danaher Corp
NYSE:DHR
|
Other
-$125m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-44%
|
|
|
Waters Corp
NYSE:WAT
|
Other
-$23.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-17%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other
-$34m
|
CAGR 3-Years
34%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other
-$86m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Alpha Teknova Inc
Glance View
Alpha Teknova, Inc. manufactures cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 231 full-time employees. The company went IPO on 2021-06-25. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions. Its processes enable it to manufacture and deliver custom, made-to-order products across all stages of development, including commercialization. The firm's processes are designed to handle as array of customer-requested inputs, which vary by volume, chemical formulation, quality specifications, container types, and transportation requirements, enabling use of its products across the scope of the life sciences market.
See Also
What is Alpha Teknova Inc's Other?
Other
-1.2m
USD
Based on the financial report for Dec 31, 2025, Alpha Teknova Inc's Other amounts to -1.2m USD.
What is Alpha Teknova Inc's Other growth rate?
Other CAGR 3Y
-56%
The average annual Other growth rates for Alpha Teknova Inc have been -56% over the past three years .
